title: Adiponectin may play a part in the pathogenesis of diabetic retinopathy.
abstract: OBJECTIVE
  To measure plasma adiponectin concentrations in patients with type 2 diabetes and to investigate any association with the severity of diabetic retinopathy, because adiponectin seems to be an important modulator for metabolic and vascular diseases.
  
  
  METHODS
  Seventy-four patients (mean age 46.8+/-5.1 years; body mass index (BMI), 26.8+/-2.10 kg/m(2)) and 54 healthy volunteers (mean age 46.8+/-5.4 years; BMI 26.47+/-2.33 kg/m(2)) were included.
  
  
  RESULTS
  Adiponectin concentrations in the patients were significantly lower than those in controls (4.71+/-2.11 microg/ml for patients, n=74; 15.95+/-3.72 microg/ml for controls, n=54; P<0.001). In the patients group there was a significant negative correlation between adiponectin and homeostasis model assessment index (r=-0.318, P=0.006 respectively). Plasma adiponectin concentrations in patients with proliferative diabetic retinopathy (n=20; 3.16+/-1.83 microg/ml) or non-proliferative diabetic retinopathy (n=24; 3.97+/-1.47 microg/ml, P=0.014) were significantly lower than those in patients without diabetic retinopathy (n=30; 6.30+/-1.57 microg/ml, P=0.001). When the presence of diabetes was defined as the final variable in the conditional logistic regression model with the adiponectin concentration as the continuous variable, adiponectin was significantly involved in the model.
  
  
  CONCLUSIONS
  The results show that adiponectin concentrations are lower in patients with type 2 diabetes and that the concentrations are associated with the severity of diabetic retinopathy. Our findings suggest that adiponectin may take part in the pathogenesis of diabetic retinopathy.
authors.affiliation: Department of Nephrology, Gülhane School of Medicine, Etlik-Ankara, Turkey. mahmutiyilmaz@yahoo.com
authors.forename: Mahmut Ilker
authors.initials: MI
authors.lastname: Yilmaz
authors.forename: Alper
authors.initials: A
authors.lastname: Sonmez
authors.forename: Cengizhan
authors.initials: C
authors.lastname: Acikel
authors.forename: Turgay
authors.initials: T
authors.lastname: Celik
authors.forename: Necati
authors.initials: N
authors.lastname: Bingol
authors.forename: Murat
authors.initials: M
authors.lastname: Pinar
authors.forename: Zeki
authors.initials: Z
authors.lastname: Bayraktar
authors.forename: Metin
authors.initials: M
authors.lastname: Ozata
mesh_terms: D052242:Adiponectin; D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000378:metabolism*; D003930:Diabetic Retinopathy / Q000209:etiology* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*; D012720:Severity of Illness Index
chemical_list: D052242:Adiponectin; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D011506:Proteins